MSDS

MATERIAL SAFETY DATA SHEET
SHEETROCK® Lightweight All Purpose Joint Compound
Ready Mixed Plus 3 with Dust Control
MSDS #61-362-001
Page 1 of 9
61362001
SECTION 1
CHEMICAL PRODUCT AND IDENTIFICATION
United States Gypsum Company
550 West Adams Street
Chicago, Illinois 60661-3637
A Subsidiary of USG Corporation
Product Safety: 1 (800) 507-8899
www.usg.com
Version Date: January 1, 2011
Version: 6
PRODUCT(S)
SHEETROCK® Lightweight All Purpose Joint Compound Ready Mixed Plus 3 with Dust Control
CHEMICAL FAMILY /
GENERAL CATEGORY
SYNONYMS
SECTION 2
HAZARD IDENTIFICATION
EMERGENCY OVERVIEW:
ΔCAUTION!
This product is not expected to produce any unusual hazards during normal use. Exposure to high dust levels may
irritate the skin, eyes, nose, throat, or upper respiratory tract. This product is formulated to reduce airborne sanding
dust and therefore significantly reduces the risk of exposure to high dust levels.
POTENTIAL HEALTH EFFECTS (See Section 11 for more information)
ACUTE :
Inhalation
Exposure to dust generated during the handling or sanding of the product may cause temporary
irritation to eyes, skin, nose, throat, and upper respiratory tract. Persons subjected to large amounts
of this dust will be forced to leave area because of nuisance conditions such as coughing, sneezing
and nasal irritation. Labored breathing may occur after excessive inhalation. If respiratory symptoms
persist, consult physician.
This product is formulated to reduce airborne sanding dust and therefore significantly reduces the risk
of exposure to high dust levels.
Eyes
Dust can cause temporary mechanical irritation of eyes. If burning, redness, itching, pain or other
symptoms persist or develop, consult physician.
Skin
None known.
Ingestion
None known.
CHRONIC:
Inhalation
Prolonged and repeated exposure to airborne free respirable crystalline silica can result in lung disease
(i.e., silicosis) and/or lung cancer. The development of silicosis may increase the risks of additional
health effects. The risk of developing silicosis is dependent upon the exposure intensity and duration.
Eyes
None known.
Skin
None known.
Ingestion
None known.
TARGET ORGANS: Eyes, skin and respiratory system.
PRIMARY ROUTES OF ENTRY: Inhalation, eyes and skin contact.

Summary of content (9 pages)